Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DM10A9S)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
6-Chloro-N-(2-morpholinoethyl)nicotinamide; CHEMBL596768; 446269-58-5; 6-chloro-N-[2-(morpholin-4-yl)ethyl]pyridine-3-carboxamide; AC1LNWHD; Oprea1_139589; MLS001010907; CTK6H1374; cid_1228702; 6-chloro-N-(2-morpholin-4-ylethyl)pyridine-3-carboxamide; MolPort-000-431-678; HMS2765K07; ZINC19397174; BDBM50307188; AKOS000162940; MCULE-8413919053; SMR000352965; ST50046456; 6-chloro-N-(2-morpholin-4-ylethyl)nicotinamide; Z32410126; F1077-0095
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | ||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||